DS
OSRH

David Shaw’s OSR Health OSRH Stock Holding History

David Shaw’s Portfolio OSRH Stock Details OSRH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-150,000
Closed -$1.57M – 4676
2023
Q3 		$1.57M Hold
150,000
– – ﹤0.01% 2771
2023
Q2 		$1.54M Hold
150,000
– – ﹤0.01% 2815
2023
Q1 		$1.51M Buy
+150,000
New +$1.52M ﹤0.01% 2883

Other funds holding OSRH

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

David Shaw's OSRH Position: Q4 2023 in Review

David Shaw sold out of OSR Health (OSRH) in Q4 2023, closing a stake of 150,000 shares — an estimated $1.57M sold.

David Shaw first reported a position in OSRH in Q1 2023 and held it in 3 quarters. The position peaked at $1.57M in Q3 2023. 24 funds tracked by Wall St. Rank hold OSRH as of Q4 2023.

  • David Shaw reported no remaining OSR Health position as of Q4 2023 after selling out during the quarter.
  • David Shaw sold 150,000 OSR Health shares in Q4 2023, an estimated $1.57M.
  • David Shaw first reported a position in OSR Health in Q1 2023 and held it in 3 quarters.
  • David Shaw's OSR Health position peaked at $1.57M in Q3 2023.
  • 24 funds tracked by Wall St. Rank held OSR Health as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.